Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries
- 15 November 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (10) , 2841-2847
Abstract
Background Although aspirin is an effective, inexpensive, and safe treatment of acute myocardial infarction, the frequency of use of aspirin in actual medical practice is not known. Elderly patients, a group with low rates of utilization of effective therapies such as thrombolytic therapy, also may be at risk of not receiving aspirin for acute myocardial infarction. To address this issue, we sought to determine the current pattern of aspirin use and to assess its effectiveness in a large, population-based sample of elderly patients hospitalized with acute myocardial infarction. Methods and Results As part of the Cooperative Cardiovascular Project Pilot, a Health Care Financing Administration initiative to improve quality of care for Medicare beneficiaries, we abstracted hospital medical records of Medicare beneficiaries who were hospitalized in Alabama, Connecticut, Iowa, or Wisconsin from June 1992 through February 1993. Among the 10 018 patients ≥65 years old who had no absolute contraindications to aspirin, 6140 patients (61%) received aspirin within the first 2 days of hospitalization. Patients who were older, had more comorbidity, presented without chest pain, and had high-risk characteristics such as heart failure and shock were less likely to receive aspirin. The use of aspirin was significantly associated with a lower mortality (OR, 0.78; 95% CI, 0.70 to 0.89) after adjustment for potential confounders. Conclusions About one third of elderly patients with acute myocardial infarction who had no contraindications to aspirin therapy did not receive it within the first 2 days of hospitalization. The elderly patients with the highest risk of death were the least likely to receive aspirin. After adjustment for differences between the treatment groups, the use of aspirin was associated with 22% lower odds of 30-day mortality. The increased use of aspirin for patients with acute myocardial infarction is an excellent opportunity to improve the delivery of care to elderly patients.Keywords
This publication has 21 references indexed in Scilit:
- Process and Outcome of Care for Acute Myocardial Infarction among Medicare Beneficiaries in Connecticut: A Quality Improvement Demonstration ProjectAnnals of Internal Medicine, 1995
- Quality of Care for Medicare Patients With Acute Myocardial InfarctionJAMA, 1995
- Relationship of Age with Eligibility for Thrombolytic Therapy and Mortality Among Patients with Suspected Acute Myocardial InfarctionJournal of the American Geriatrics Society, 1994
- The Benefits of Aspirin in Acute Myocardial InfarctionArchives of internal medicine (1960), 1994
- Age‐Related Variability in the Use of Cardiovascular Imaging ProceduresJournal of the American Geriatrics Society, 1993
- Acute Myocardial Infarction in the Medicare PopulationJAMA, 1992
- Do the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?New England Journal of Medicine, 1992
- Selection of Patients for Coronary Angiography and Coronary Revascularization Early after Myocardial Infarction: Is There Evidence for a Gender Bias?Annals of Internal Medicine, 1992
- Diagnostic Testing in Acute Myocardial Infarction: Does Patient Age Influence Utilization Patterns?American Journal of Epidemiology, 1991
- Guidelines for the early management of patients with acute myocardial infarctionJACC, 1990